<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37204564</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>ALS-plus related clinical and genetic study from China.</ArticleTitle><Pagination><StartPage>3557</StartPage><EndPage>3566</EndPage><MedlinePgn>3557-3566</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-023-06843-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. An increasing number of researchers have found extra motor features in ALS, which are also called ALS-plus syndromes. Besides, a great majority of ALS patients also have cognitive impairment. However, clinical surveys of the frequency and genetic background of ALS-plus syndromes are rare, especially in China.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We investigated a large cohort of 1015 patients with ALS, classifying them into six groups according to different extramotor symptoms and documenting their clinical manifestations. Meanwhile, based on their cognitive function, we divided these patients into two groups and compared demographic characteristics. Genetic screening for rare damage variants (RDVs) was also performed on 847 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">As a result, 16.75% of patients were identified with ALS-plus syndrome, and 49.5% of patients suffered cognitive impairment. ALS-plus group had lower ALSFRS-R scores, longer diagnostic delay time, and longer survival times, compared to ALS pure group. RDVs occurred less frequently in ALS-plus patients than in ALS-pure patients (P = 0.042) but showed no difference between ALS-cognitive impairment patients and ALS-cognitive normal patients. Besides, ALS-cognitive impairment group tends to harbour more ALS-plus symptoms than ALS-cognitive normal group (P = 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In summary, ALS-plus patients in China are not rare and show multiple differences from ALS-pure patients in clinical and genetic features. Besides, ALS-cognitive impairment group tends to harbour more ALS-plus syndrome than ALS-cognitive normal group. Our observations correspond with the theory that ALS involves several diseases with different mechanisms and provide clinical validation.</AbstractText><CopyrightInformation>&#xa9; 2023. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Management Center, Xiangya Hospital, Central South University, Changsha, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Qilu Hospital of Shandong University, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Qianqian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Pan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yanchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yiting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wanzhen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Xiaorong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xuxiong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, 410008, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jifeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, 410008, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, 410008, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Basic Medical Science, Central South University, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Beisha</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, 410008, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xuewei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Health Management Center, Xiangya Hospital, Central South University, Changsha, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Junling</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5117-5204</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, 410008, People's Republic of China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, People's Republic of China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057210" MajorTopicYN="N">Delayed Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="Y">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS-plus syndrome</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Extrapyramidal impairment</Keyword><Keyword MajorTopicYN="N">Neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">Rare damage variants</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37204564</ArticleId><ArticleId IdType="doi">10.1007/s10072-023-06843-4</ArticleId><ArticleId IdType="pii">10.1007/s10072-023-06843-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A et al (2017) Amyotrophic lateral sclerosis. Lancet. 390:2084&#x2013;2098</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17:94&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pubmed">29154141</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M, Brown RH Jr (2018) Genetics of amyotrophic lateral sclerosis. Cold Spring Harb Perspect Med 8:a024125</Citation><ArticleIdList><ArticleId IdType="pubmed">28270533</ArticleId><ArticleId IdType="pmc">5932579</ArticleId><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA (2017) Wray, N R &amp; Henderson, R D Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity. Expert Rev Neurother 17:561&#x2013;577</Citation><ArticleIdList><ArticleId IdType="pubmed">27983884</ArticleId><ArticleId IdType="doi">10.1080/14737175.2017.1273772</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Swash M (2015) The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey. J Neurol Neurosurg Psychiatry 86:667&#x2013;673</Citation><ArticleIdList><ArticleId IdType="pubmed">25644224</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2014-308946</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJ, Koppers M et al (2013) Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 125:777&#x2013;794</Citation><ArticleIdList><ArticleId IdType="pubmed">23673820</ArticleId><ArticleId IdType="pmc">3661910</ArticleId><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Schulte DJ et al (2015) Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin 33:855&#x2013;876</Citation><ArticleIdList><ArticleId IdType="pubmed">26515626</ArticleId><ArticleId IdType="pmc">4628785</ArticleId><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H, Gao K, Jankovic J (2014) The role of FUS gene variants in neurodegenerative diseases. Nat Rev Neurol 10:337&#x2013;348</Citation><ArticleIdList><ArticleId IdType="pubmed">24840975</ArticleId><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId></ArticleIdList></Reference><Reference><Citation>Rademakers R, Stewart H, Dejesus-Hernandez M et al (2010) Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis. Muscle Nerve 42:170&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">20544928</ArticleId><ArticleId IdType="pmc">2969843</ArticleId><ArticleId IdType="doi">10.1002/mus.21665</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui B, Cui L, Gao J et al (2015) Cognitive Impairment in Chinese patients with sporadic amyotrophic lateral sclerosis. PloS One 10:e0137921</Citation><ArticleIdList><ArticleId IdType="pubmed">26367133</ArticleId><ArticleId IdType="pmc">4569418</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0137921</ArticleId></ArticleIdList></Reference><Reference><Citation>Niblock M, Smith BN, Lee Y-B et al (2016) Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD. Acta Neuropathol Commun 4:18</Citation><ArticleIdList><ArticleId IdType="pubmed">26916632</ArticleId><ArticleId IdType="pmc">4766718</ArticleId><ArticleId IdType="doi">10.1186/s40478-016-0289-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromicho M, Pinto S, Gisca E et al (2018) Frequency of C9orf72 hexanucleotide repeat expansion and SOD1 mutations in Portuguese patients with amyotrophic lateral sclerosis. Neurobiol Aging 70:325.e7&#x2013;325.e15. https://doi.org/10.1016/j.neurobiolaging.2018.05.009 Epub 2018 May 14. 2018; 70, 325.e7-325.e15</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.05.009</ArticleId><ArticleId IdType="pubmed">29861044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K, Yagi T, Cammack AJ et al (2016) Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum Mol Genet 25:1803&#x2013;1813</Citation><ArticleIdList><ArticleId IdType="pubmed">26931465</ArticleId><ArticleId IdType="pmc">4986334</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddw052</ArticleId></ArticleIdList></Reference><Reference><Citation>Floris G, Borghero G, Cannas A et al (2014) Constructional apraxia in frontotemporal dementia associated with the C9orf72 mutation: broadening the clinical and neuropsychological phenotype. Amyotroph Lateral Scler Frontotemporal Degener 16:1&#x2013;8</Citation></Reference><Reference><Citation>Wilke C, Pomper JK, Biskup S et al (2016) Atypical parkinsonism in C9orf72 expansions: a case report and systematic review of 45 cases from the literature. J Neurol 263:558&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pubmed">26810719</ArticleId><ArticleId IdType="doi">10.1007/s00415-016-8021-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Floris G, Borghero G, Cannas A et al (2012) Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: a peculiar phenotype? J Neurol 259:1749&#x2013;1751</Citation><ArticleIdList><ArticleId IdType="pubmed">22323211</ArticleId><ArticleId IdType="pmc">4164047</ArticleId><ArticleId IdType="doi">10.1007/s00415-012-6444-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, Brandmeir NJ, Kwong LK et al (2008) Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 65:636&#x2013;641</Citation><ArticleIdList><ArticleId IdType="pubmed">18474740</ArticleId><ArticleId IdType="doi">10.1001/archneur.65.5.636</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">23686809</ArticleId><ArticleId IdType="pmc">3785076</ArticleId><ArticleId IdType="doi">10.1002/ana.23937</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Al-Chalabi A, Baker MR et al (2020) A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 131:1975&#x2013;1978</Citation><ArticleIdList><ArticleId IdType="pubmed">32387049</ArticleId><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId></ArticleIdList></Reference><Reference><Citation>McCluskey L, Vandriel S, Elman L et al (2014) ALS-Plus syndrome: non-pyramidal features in a large ALS cohort. J Neurol Sci 345:118&#x2013;124</Citation><ArticleIdList><ArticleId IdType="pubmed">25086858</ArticleId><ArticleId IdType="pmc">4177937</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2014.07.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert RM, Fahn S, Mitsumoto H et al (2010) Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Mov Disord 25:1868&#x2013;1875</Citation><ArticleIdList><ArticleId IdType="pubmed">20669307</ArticleId><ArticleId IdType="doi">10.1002/mds.23200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 66:265&#x2013;267</Citation><ArticleIdList><ArticleId IdType="pubmed">16434671</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Yuan Y, Wang M et al (2021) Mutation spectrum of amyotrophic lateral sclerosis in Central South China. Neurobiol Aging 107:181&#x2013;188</Citation><ArticleIdList><ArticleId IdType="pubmed">34275688</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.06.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:e164</Citation><ArticleIdList><ArticleId IdType="pubmed">20601685</ArticleId><ArticleId IdType="pmc">2938201</ArticleId><ArticleId IdType="doi">10.1093/nar/gkq603</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao P, Yuan Y, Liu Z et al (2022) Association of variants in the KIF1A gene with amyotrophic lateral sclerosis. Transl Neurodegener 11:46</Citation><ArticleIdList><ArticleId IdType="pubmed">36284339</ArticleId><ArticleId IdType="pmc">9597953</ArticleId><ArticleId IdType="doi">10.1186/s40035-022-00320-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhao T, Zhang Y et al (2018) Performance evaluation of pathogenicity-computation methods for missense variants. Nucleic Acids Res 46:7793&#x2013;7804</Citation><ArticleIdList><ArticleId IdType="pubmed">30060008</ArticleId><ArticleId IdType="pmc">6125674</ArticleId><ArticleId IdType="doi">10.1093/nar/gky678</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405&#x2013;424</Citation><ArticleIdList><ArticleId IdType="pubmed">25741868</ArticleId><ArticleId IdType="pmc">4544753</ArticleId><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul F, Erdfelder E, Lang AG et al (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175&#x2013;191</Citation><ArticleIdList><ArticleId IdType="pubmed">17695343</ArticleId><ArticleId IdType="doi">10.3758/BF03193146</ArticleId></ArticleIdList></Reference><Reference><Citation>Poewe W (2008) Non-motor symptoms in Parkinson&#x2019;s disease. Eur J Neurol 15:14&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">18353132</ArticleId><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02056.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T, Kitagawa K, Arai K (2020) Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis. Neuropathology. 40:40&#x2013;56</Citation><ArticleIdList><ArticleId IdType="pubmed">31802540</ArticleId><ArticleId IdType="doi">10.1111/neup.12606</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammad M, Silva A, Glass J et al (2007) Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology. 69:2236&#x2013;2242</Citation><ArticleIdList><ArticleId IdType="pubmed">18071143</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000286948.99150.16</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto H, Akamatsu M, Hirano M et al (2014) Multiple system involvement in a Japanese patient with a V31A mutation in the SOD1 gene. Amyotroph Lateral Scler Frontotemporal Degener 15:312&#x2013;314</Citation><ArticleIdList><ArticleId IdType="pubmed">24611504</ArticleId><ArticleId IdType="doi">10.3109/21678421.2013.873051</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawata A, Kato S, Hayashi H et al (1997) Prominent sensory and autonomic disturbances in familial amyotrophic lateral sclerosis with a Gly93Ser mutation in the SOD1 gene. J Neurol Sci 153:82&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pubmed">9455983</ArticleId><ArticleId IdType="doi">10.1016/S0022-510X(97)00176-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini F, Battistini S, Mancuso M et al (2010) D90A-SOD1 mutation in ALS: the first report of heterozygous Italian patients and unusual findings. Amyotroph Lateral Scler 11:216&#x2013;219</Citation><ArticleIdList><ArticleId IdType="pubmed">20184519</ArticleId><ArticleId IdType="doi">10.3109/17482960902721642</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjanovic IV, Selak-Djokic B, Peric S et al (2017) Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia. J Neurol 264:1091&#x2013;1098</Citation><ArticleIdList><ArticleId IdType="pubmed">28444446</ArticleId><ArticleId IdType="doi">10.1007/s00415-017-8495-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, Bruneteau G, Munerati E et al (2009) Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis. Mov Disord 24:2143&#x2013;2148</Citation><ArticleIdList><ArticleId IdType="pubmed">19735090</ArticleId><ArticleId IdType="doi">10.1002/mds.22762</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Chi&#xf2; A, Pagani M et al (2019) Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study. J Neurol 266:1633&#x2013;1642</Citation><ArticleIdList><ArticleId IdType="pubmed">30949819</ArticleId><ArticleId IdType="doi">10.1007/s00415-019-09305-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y, Tan C-F, Onodera O et al (2008) Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol 116:169</Citation><ArticleIdList><ArticleId IdType="pubmed">18481073</ArticleId><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Merner ND, Girard SL, Catoire H et al (2012) Exome sequencing identifies FUS mutations as a cause of essential tremor. Am J Hum Genet 91:313&#x2013;319</Citation><ArticleIdList><ArticleId IdType="pubmed">22863194</ArticleId><ArticleId IdType="pmc">3415547</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2012.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L, Del Bo R, Castellotti B et al (2010) Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet 47:190&#x2013;194</Citation><ArticleIdList><ArticleId IdType="pubmed">19861302</ArticleId><ArticleId IdType="doi">10.1136/jmg.2009.071027</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita K, Matsubara T, Miyamoto R et al (2019) Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report. BMC Neurol 19:168</Citation><ArticleIdList><ArticleId IdType="pubmed">31319800</ArticleId><ArticleId IdType="pmc">6637486</ArticleId><ArticleId IdType="doi">10.1186/s12883-019-1402-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao S, Yokota O, Nanba R et al (2012) Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia. J Neurol Sci 323:147&#x2013;153</Citation><ArticleIdList><ArticleId IdType="pubmed">23026537</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2012.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman J, Waters C, Mitsumoto H et al (2014) Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72 (P4.105). Neurology. 82:P4.105</Citation></Reference><Reference><Citation>Wenning GK, Tison F, Ben Shlomo Y et al (1997) Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12:133&#x2013;147</Citation><ArticleIdList><ArticleId IdType="pubmed">9087971</ArticleId><ArticleId IdType="doi">10.1002/mds.870120203</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O et al (2009) Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 10:310&#x2013;323</Citation><ArticleIdList><ArticleId IdType="pubmed">19922118</ArticleId><ArticleId IdType="pmc">3515205</ArticleId><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y (2004) Progress in the basic and clinical aspects of Parkinson&#x2019;s disease. Rinsho Shinkeigaku 44:741&#x2013;750</Citation><ArticleIdList><ArticleId IdType="pubmed">15651281</ArticleId></ArticleIdList></Reference><Reference><Citation>Su WM, Cheng YF, Jiang Z et al (2021) Predictors of survival in patients with amyotrophic lateral sclerosis: a large meta-analysis. EBioMedicine. 74:103732</Citation><ArticleIdList><ArticleId IdType="pubmed">34864363</ArticleId><ArticleId IdType="pmc">8646173</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2021.103732</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjani R, Larson TC, Wagner L et al (2018) Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through. Amyotroph Lateral Scler Frontotemporal Degener 2022:1&#x2013;9</Citation></Reference><Reference><Citation>Ringholz GM, Appel SH, Bradshaw M et al (2005) Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 65:586&#x2013;590</Citation><ArticleIdList><ArticleId IdType="pubmed">16116120</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000172911.39167.b6</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergner CG, Neuhofer CM, Funke C et al (2020) Case report: association of a variant of unknown significance in the FIG4 gene with frontotemporal dementia and slowly progressing motoneuron disease: a case report depicting common challenges in clinical and genetic diagnostics of rare neuropsychiatric and neurologic disorders. Front Neurosci 14:559670</Citation><ArticleIdList><ArticleId IdType="pubmed">33424531</ArticleId><ArticleId IdType="pmc">7793702</ArticleId><ArticleId IdType="doi">10.3389/fnins.2020.559670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung EJ, Hwang JH, Lee MJ et al (2014) Expansion of the clinicopathological and mutational spectrum of Perry syndrome. Parkinsonism Relat Disord 20:388&#x2013;393</Citation><ArticleIdList><ArticleId IdType="pubmed">24484619</ArticleId><ArticleId IdType="doi">10.1016/j.parkreldis.2014.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanowski L, Sitek EJ, Dulski J et al (2020) Cognitive and behavioral profile of Perry syndrome in two families. Parkinsonism Relat Disord 77:114&#x2013;120</Citation><ArticleIdList><ArticleId IdType="pubmed">32717578</ArticleId><ArticleId IdType="doi">10.1016/j.parkreldis.2020.05.019</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C, Sedlmeier R, Meyer T et al (2004) Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 63:724&#x2013;726</Citation><ArticleIdList><ArticleId IdType="pubmed">15326253</ArticleId><ArticleId IdType="doi">10.1212/01.WNL.0000134608.83927.B1</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Yang L, Tang L et al (2017) DCTN1 gene analysis in Chinese patients with sporadic amyotrophic lateral sclerosis. PloS One 12:e0182572</Citation><ArticleIdList><ArticleId IdType="pubmed">28792508</ArticleId><ArticleId IdType="pmc">5549744</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0182572</ArticleId></ArticleIdList></Reference><Reference><Citation>Broustal O, Camuzat A, Guillot-No&#xeb;l L et al (2010) FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. J Alzheimers Dis 22:765&#x2013;769</Citation><ArticleIdList><ArticleId IdType="pubmed">21158017</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M, Bieniek KF, Lin WL et al (2015) A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration. Acta Neuropathol 130:145&#x2013;157</Citation><ArticleIdList><ArticleId IdType="pubmed">25917047</ArticleId><ArticleId IdType="pmc">5039014</ArticleId><ArticleId IdType="doi">10.1007/s00401-015-1431-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney RK, Murphy J, Forshew D et al (2005) The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 65:1774&#x2013;1777</Citation><ArticleIdList><ArticleId IdType="pubmed">16344521</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000188759.87240.8b</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf J, Safer A, Wohrle JC et al (2014) Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis - data from a population-based registry. J Neurol Sci 345:164&#x2013;167</Citation><ArticleIdList><ArticleId IdType="pubmed">25086855</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2014.07.033</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Hou Y, Li C et al (2021) Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 92:688&#x2013;693</Citation><ArticleIdList><ArticleId IdType="pubmed">33563800</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2020-325701</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y, Shimizu T, Matsuda C et al (2018) Non-motor manifestations in ALS patients with tracheostomy and invasive ventilation. Muscle Nerve 57:735&#x2013;741</Citation><ArticleIdList><ArticleId IdType="pubmed">29105161</ArticleId><ArticleId IdType="doi">10.1002/mus.26004</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewan R, Chia R, Ding J et al (2021) Pathogenic Huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis. Neuron. 109:448&#x2013;460.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">33242422</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2020.11.005</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>